ATE174385T1 - Immunglobulin-a1-proteasen (iga1-proteasen), verfahren zur gentechnologischen herstellung dieses enzymtyps sowie impfstoffe, die die enzyme und fragmente davon enthalten, zur immunisierung gegen bakterielle meningitis und andere, durch iga1-proteaseproduzierende bakterien verursachte krankheiten - Google Patents

Immunglobulin-a1-proteasen (iga1-proteasen), verfahren zur gentechnologischen herstellung dieses enzymtyps sowie impfstoffe, die die enzyme und fragmente davon enthalten, zur immunisierung gegen bakterielle meningitis und andere, durch iga1-proteaseproduzierende bakterien verursachte krankheiten

Info

Publication number
ATE174385T1
ATE174385T1 AT90905191T AT90905191T ATE174385T1 AT E174385 T1 ATE174385 T1 AT E174385T1 AT 90905191 T AT90905191 T AT 90905191T AT 90905191 T AT90905191 T AT 90905191T AT E174385 T1 ATE174385 T1 AT E174385T1
Authority
AT
Austria
Prior art keywords
protease
iga1
proteases
influenzae
iga
Prior art date
Application number
AT90905191T
Other languages
English (en)
Inventor
Mogens Kilian
Knud Poulsen
Original Assignee
Mogens Kilian
Knud Poulsen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mogens Kilian, Knud Poulsen filed Critical Mogens Kilian
Application granted granted Critical
Publication of ATE174385T1 publication Critical patent/ATE174385T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092Streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/095Neisseria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/102Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT90905191T 1989-03-17 1990-03-16 Immunglobulin-a1-proteasen (iga1-proteasen), verfahren zur gentechnologischen herstellung dieses enzymtyps sowie impfstoffe, die die enzyme und fragmente davon enthalten, zur immunisierung gegen bakterielle meningitis und andere, durch iga1-proteaseproduzierende bakterien verursachte krankheiten ATE174385T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK130889A DK130889A (da) 1989-03-17 1989-03-17 Immunoglobulin a1-proteaser (iga1-proteaser), fremgangsmaade til genteknologisk fremstilling af saadanne enzymer samt vaccine indeholdende enzymerne og fragmenter deraf til immunisering mod bakteriel meningitis og andre sygdomme fremkaldt af iga1-protease-producerende bakterier

Publications (1)

Publication Number Publication Date
ATE174385T1 true ATE174385T1 (de) 1998-12-15

Family

ID=8103403

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90905191T ATE174385T1 (de) 1989-03-17 1990-03-16 Immunglobulin-a1-proteasen (iga1-proteasen), verfahren zur gentechnologischen herstellung dieses enzymtyps sowie impfstoffe, die die enzyme und fragmente davon enthalten, zur immunisierung gegen bakterielle meningitis und andere, durch iga1-proteaseproduzierende bakterien verursachte krankheiten

Country Status (10)

Country Link
EP (1) EP0463073B1 (de)
JP (1) JPH04503756A (de)
AT (1) ATE174385T1 (de)
AU (1) AU630443B2 (de)
CA (1) CA2049984A1 (de)
DE (1) DE69032821D1 (de)
DK (1) DK130889A (de)
FI (1) FI100723B (de)
NO (1) NO304745B1 (de)
WO (1) WO1990011367A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965424A (en) * 1991-01-11 1999-10-12 Boehringer Mannheim Gmbh Methods for making neisseria or hemophilus IgA protease and DNA encoding the proteases
DE4140699A1 (de) * 1991-01-11 1992-07-16 Boehringer Mannheim Gmbh Rekombinante iga-protease
GB9201013D0 (en) * 1992-01-17 1992-03-11 Animal Health Inst Vaccines
US6245337B1 (en) 1994-08-25 2001-06-12 Washington University Haemophilus adherence and penetration proteins
US6676948B2 (en) 1994-08-25 2004-01-13 Washington University Haemophilus adherence and penetration proteins
WO1996009395A2 (de) * 1994-09-21 1996-03-28 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Arzneimittel zur prophylaxe und behandlung von und diagnostika zur erkennung von autoimmunkrankheiten und viralen erkrankungen
US6559359B1 (en) * 1996-09-09 2003-05-06 Loyola University Of Chicago Plant retroviral polynucleotides and methods for use thereof
DK0895537T3 (da) * 1997-01-21 2005-03-29 Max Planck Gesellschaft IGA1 proteasefragment som bærerpeptid
DE19741955A1 (de) * 1997-09-23 1999-04-01 Max Planck Gesellschaft Mittel gegen bakterielle Meningitis
JP5438886B2 (ja) * 2003-03-07 2014-03-12 タフツ メディカル センター インコーポレイテッド IgA1沈着症の治療
GB0408977D0 (en) 2004-04-22 2004-05-26 Chiron Srl Immunising against meningococcal serogroup Y using proteins
US8440191B2 (en) 2005-11-18 2013-05-14 Tufts Medical Center Clearance of abnormal IGA1 in IGA1 deposition diseases
US8841109B2 (en) 2009-04-20 2014-09-23 The University Of Kansas IGA1 protease polypeptide agents and uses thereof
RU2407792C1 (ru) * 2009-10-05 2010-12-27 Учреждение Российской академии наук Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова РАН СПОСОБ ПОЛУЧЕНИЯ IgAl-ПРОТЕАЗЫ ИЗ КУЛЬТУРЫ NEISSERIA MENINGITIDIS СЕРОГРУППЫ А И ИММУНОГЕННЫЙ ПРЕПАРАТ НА ЕЕ ОСНОВЕ
RU2426126C1 (ru) * 2010-05-28 2011-08-10 Федеральное государственное учреждение науки "Казанский научно-исследовательский институт эпидемиологии и микробиологии" Роспотребнадзора СПОСОБ ОПРЕДЕЛЕНИЯ IgA-ПРОТЕИНАЗНОЙ АКТИВНОСТИ
GB201120634D0 (en) * 2011-11-30 2012-01-11 Univ Sheffield Adjuvant polypeptide
WO2017137085A1 (en) 2016-02-11 2017-08-17 Sanofi Pasteur Meningitidis vaccines comprising subtilinases

Also Published As

Publication number Publication date
EP0463073B1 (de) 1998-12-09
AU630443B2 (en) 1992-10-29
NO304745B1 (no) 1999-02-08
NO913665D0 (no) 1991-09-17
FI100723B (fi) 1998-02-13
NO913665L (no) 1991-11-18
AU5344790A (en) 1990-10-22
CA2049984A1 (en) 1990-09-18
DE69032821D1 (de) 1999-01-21
JPH04503756A (ja) 1992-07-09
DK130889A (da) 1990-09-18
FI914356A0 (fi) 1991-09-17
EP0463073A1 (de) 1992-01-02
DK130889D0 (da) 1989-03-17
WO1990011367A1 (en) 1990-10-04

Similar Documents

Publication Publication Date Title
ATE174385T1 (de) Immunglobulin-a1-proteasen (iga1-proteasen), verfahren zur gentechnologischen herstellung dieses enzymtyps sowie impfstoffe, die die enzyme und fragmente davon enthalten, zur immunisierung gegen bakterielle meningitis und andere, durch iga1-proteaseproduzierende bakterien verursachte krankheiten
Sugai et al. Purification and molecular characterization of glycylglycine endopeptidase produced by Staphylococcus capitis EPK1
Joshi et al. Cloning of a cuticle-degrading protease from the entomopathogenic fungus, Beauveria bassiana
RU95117238A (ru) Нуклеиновая кислота, рекомбинантная плазмида, рекомбинантный вектор, белок, синтетический пептид, химерная молекула, иммуногенная композиция, антисыворотка или антитела
CA2356836A1 (en) Novel streptococcus antigens
FI102539B1 (fi) Nitriilihydrataasiaktiivisuutta omaavaa polypeptidiä koodaava DNA-fragmentti, geenin sisältävä transformantti ja menetelmä amidien tuottamiseksi transformanttia käyttäen
DE60140626D1 (de) Verfahren zur fermentativen herstellung von heterologen genprodukten in milchsäurebakterien
Yoshimoto et al. Cloning and expression of subtilisin amylosacchariticus gene
ATE244307T1 (de) Rekombinante proteine des filamentoesen haemaglutinins von bordetella,im besonderen bordetella pertusis, herstellungsverfahren und ihre verwendung zur herstellung von fremdproteinen oder vakzinen
Wintermeyer et al. Characterization of legiolysin (lly), responsible for haemolytic activity, colour production and fluorescence of Legionella pneumophila
US5352588A (en) Streptococcal immunoglobulin a binding protein encoded by emmL2.2
WO1991018101A1 (en) Process for producing protein
KR960701096A (ko) 그룹 B 스트렙토코커스의 많은 균주들에 대한 면역성을 제공하는 세포 표면 단백질인 Rib 단백질, 그 단백질의 정제방법, 시약키트 및 제약조성물(PROTEIN RIB. A CELL SURFACE PROTEIN THAT CONFERS IMMUNITY TO MANY STRAINS OF THE GROUP B STREPTOCOCCUS; PROCESS FOR PURIFICATION OF THE PROTEIN, PEAGENT KIT AND PHARMACEUTICAL COMPOSITION)
RU2005101623A (ru) Вирулентные гены, белки и их применение
DK128490D0 (da) Renset gensekvens, som koder for protein ia, ib eller begge fra neisseria gonorrhoeae, rekombinantvektorer og organismer indeholdende sekvenser, dens fremstilling og anvendelse, neisseria-stamme og dennes paavisning
JP5044085B2 (ja) 原核宿主細胞における組換えタンパク質の生産
Nomura et al. Carboxy terminal region of haemolysin of Aeromonas sobria triggers dimerization
Terauchi et al. Cloning of the gene coding for Staphylococcus intermedius exfoliative toxin and its expression in Escherichia coli
DE3878553T2 (de) Klonierung und sequenzierung des gens, das fuer eine neue pilinische untereinheit von bordetella pertussis kodiert.
JPH04502260A (ja) N―アセチルムラミダーゼ m1
AU614754B2 (en) Treatment and diagnosis of footrot using the basic protease of b.nodosus.
Igarashi et al. Detection of dextranase‐producing gram‐negative oral bacteria
AU638042B2 (en) Modified proteases and their use in foodstuffs
Gotschlich et al. Gonococcal protein III. Purification and chemical characterization of the protein, and the DNA sequence of the structural gene
Chestukhina et al. Amino acid sequences from the N-terminal domain of Bacillus thuringiensis, subspecies alesti, δ-endotoxin: Hypervariable regions of Bacillus thuringiensis δ-endotoxms